View More View Less
  • 1 The MOE Key Laboratory for Standardization of Chinese Medicines and The SATCM Key, Laboratory for New Resources and Quality Evaluation of Chinese Medicines, 1200 Cailun Road, Zhangjiang Hi-Tech Park, Shanghai, 201210, China
  • 2 The Institute of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, 1200 Cailun Road, Zhangjiang Hi-Tech Park, Shanghai, 201210, China
  • 3 Shanghai R&D Centre for Standardization of Chinese Medicines, 1200 Cailun Road, Zhangjiang Hi-Tech Park, Shanghai, 201210, China
Restricted access

Summary

Harmaline and harmine accounted for more than 70% in composition in extracts of P. harmala. More attention, however, should be paid to the other alkaloids which would be favorable or unfavorable to the efficacy and safety of the products. It was necessary to determine these trace alkaloids in the extracts; thereafter, most of them have been characterized. Diglycoside vasicine, vasicine, vasicinone, harmalol, harmol, tetrahydroharmine, 8-hydroxy-harmine, ruine, harmaline, and harmine were separated and identified with reference substances and characteristic MS spectra in extracts by liquid chromatography-electrospray ionization-mass spectrometry (LC-ESI-MS) and high-performance liquid chromatography (HPLC). Three trace alkaloids, vasicine, harmalol, and harmol were determined using the developed chromatographic separation method subsequently. The average contents of vasicine, harmalol, and harmol in extracts of ten batches were 2.53 ± 0.73, 0.54 ± 0.19, and 0.077 ± 0.03%, respectively. The total content of the three alkaloids was 3.23 ± 0.90% (from 1.81 to 4.48%). For rough estimation of all the relative alkaloids except of harmaline and harmine, the average total areas of all peaks in extracts varied from 4.35 to 26.64% detected at 220, 254, 265, 280, and 380 nm, respectively. The results indicated that area normalization method was powerless for the quality evaluation for traditional herb medicine consisting of numerous compounds with highly differential features. It might be concluded that LC-MS or HPLC could be utilized as a qualitative and quantitative analytical method for quality control of the extracts from seeds of P. harmala L.

  • [1]. L. EL-Bahri R. Chemli 1991 Vet. Hum. Toxicol. 33 276277.

  • [2]. M. Massoud J. Hossein S. Porooz 2002 Iran. J. Pharmacol. Ther. 1 14.

  • [3]. C.H. Wang J. Liu L.M. Zheng Y.M. Lin X.G. Zou M. Chen D.J. Sun 2002 Chin. Pharm. J. 37 211215.

  • [4]. J.S. Glasby 1975 Encyclopedia of the alkaloids Plenum Press New York 658.

  • [5]. O.Y. Khan 1990 Studies in the chemical constituents of Peganum harmala University of Karachi Research Institute of Chemistry, Doctor thesis Pakistan 2641.

    • Search Google Scholar
    • Export Citation
  • [6]. B. Blum H. Weizmann G.M. Simpson D. Krasilowsky I.S. Kulcsar H. Merskey 1964 Psychopharmacologia 6 307310.

  • [7]. N. Ginovart J.H. Meyer A. Boovariwala D. Hussey E.A. Rabiner S. Houle A.A. Wilson 2006 J. Cereb. Blood Flow Metab. 3 330344.

  • [8]. M. Iurlo G. Leone B. Schilström L. Linnér G. Nomikos P. Hertel B. Silvestrini H. Svensson 2001 Psychopharmacology 159 98104.

  • [9]. Y. Song D. Kesuma J. Wang Y. Deng J. Duan J.H. Wang R.Z. Qi 2004 Biochem. Biophys. Res. Commun. 317 128132.

  • [10]. E.E. Wright J.L. Bird J.M. Feldman 1979 Res. Commun. Chem. Pathol. Pharmacol. 24 259272.

  • [11]. M. Canessa E. Jaimovich M. de la Fuente 1973 J. Membr. Biol. 13 263282.

  • [12]. Z.Y. Song J.R. Liu X.L. Lu L.J. Wang 2006 Chin. Med. Mat. 29 571573.

  • [13]. J. Jiménez L. Riverón-Negrete F. Abdullaev J. Espinosa-Aguirre R. Rodríguez-Arnaiz 2008 Exp. Toxicol. Pathol. 60 381389.

  • [14]. E.N. Gaviraj G.R. Babu U.D. Murthy 1998 Indian Drugs 35 471474.

  • [15]. A. Astulla K. Zaima Y. Matsuno Y. Hirasawa W. Ekasari A. Widyawaruyanti N.C. Zaini H. Morita 2008 Nat. Med. 62 470472.

  • [16]. G.C. Di F. Delmas E. Ollivier R. Elias G. Balansard P. Timon-David 2004 Exp. Parasitol. 106 6774.

  • [17]. D. Bian G.H. Li H.Q. Zhang 1987 Acta Pharmacol. Sin. 8 477480.

  • [18]. J. Bruinvels T.L. Sourkes 1968 Eur. J. Pharmacol. 4 3139.

  • [19]. D.H. Aarons G.V. Rossi R.F. Orzechowski 1977 J. Pharm. Sci. 66 12441248.

  • [20]. X.Y. Zheng Z.J. Zhang G.X. Chou T. Wu X.M. Cheng C.H. Wang Z.T. Wang 2009 Arch. Pharm. Res. 32 12451251.

  • [21]. X.M. Chen Y.Q. Liu H.D. Xie C.H. Wang Z.T. Wang 2008 Chin. J. Pharm. 39 443446.

  • [22]. O.P. Gupta K.K. Anand B.J. Ghatak C.K. Atal 1978 Indian J. Exp. Biol. 16 10751077.

  • [23]. C.H. Wang J. Liu Y.M. Lin 2002 Chin. Hosp. Pharm. J. 22 139141.

  • [24]. R. Zayed M. Wink 2005 Z. Naturforsch. C 60 451458.

  • [25]. R. Kikura-Hanajiri M. Hayashi K. Saisho Y. Goda 2005 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 825 2937.

  • [26]. F. Bianchi M. Careri C. Corradini I. Elviri A. Mangia I. Zagnoni 2005 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 825 193200.

    • Search Google Scholar
    • Export Citation
  • [27]. M.T. Galceran E. Moyano L. Puignou P. Pais 1996 J. Chromatogr. A 730 185194.

  • [28]. J.A. Duan R.H. Zhou S.X. Zhao M.S. Wang Z.T. Che 1998 J. Chin. Pharm. Univ. 29 2123.

  • [29]. X.L. Tian D.J. Sun N.S. Du 2003 J. Xinjiang Med. Univ. 26 113116.

  • [30]. W. Schliemann B. Schneider V. Wray J. Schmidt M. Nimtz A. Porzel H. Böhm 2006 Phytochemistry 67 191201.

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Jun 2020 0 6 5
Jul 2020 9 3 2
Aug 2020 5 0 0
Sep 2020 4 0 0
Oct 2020 6 0 0
Nov 2020 10 0 0
Dec 2020 0 0 0